Topical imiquimod

In this ever-expanding world of immunologic advancements, Drs Langley and Pearson have undertaken this timely, succinct review of imiquimod. Given its direct actions on monocytes and macrophages, as well as the many diverse cytokine effects that follow from these events, topical imiquimod has alread...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of dermatological treatment 2001, Vol.12 (1), p.37-40
Main Authors: Pearson, GW, Langley, RGB
Format: Article
Language:English
Subjects:
Adjuvants, Immunologic - administration & dosage
Adjuvants, Immunologic - adverse effects
Adjuvants, Immunologic - pharmacology
Adjuvants, Immunologic - therapeutic use
Administration, Topical
Aminoquinolines - administration & dosage
Aminoquinolines - adverse effects
Aminoquinolines - pharmacology
Aminoquinolines - therapeutic use
Biological and medical sciences
Condylomata Acuminata - drug therapy
Cytokine Human Papilloma Virus Imiquimod Immune Response Modifier Immunomodulator
Humans
Immunomodulators
Medical sciences
Ointments
Pharmacology. Drug treatments
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In this ever-expanding world of immunologic advancements, Drs Langley and Pearson have undertaken this timely, succinct review of imiquimod. Given its direct actions on monocytes and macrophages, as well as the many diverse cytokine effects that follow from these events, topical imiquimod has already solidly established itself as a successful treatment for condylomata and molluscum, and will likely show continued therapeutic applications in the future. ( J Dermatol Treat (2001) 12: 37-40)
ISSN:0954-6634
1471-1753
DOI:10.1080/095466301750163572